• UCLA Health
  • myUCLAhealth
  • School of Medicine
U Magazine

U Magazine

U Magazine
  • Home
  • Current Issue
  • Centennial Campaign for UCLA Issue
  • Browse U Magazine
  • Letters to the Editor
  • Subscribe
  • Contact
  • UCLA Health
  • myUCLAhealth
  • School of Medicine

U Magazine

Browse U Magazine

  1. Home
  2. Browse U Magazine
Share this
The Cutting Edge

Biomarkers Could Give Cancer Patients Better Survival Estimates

  Biomarkers Could Give Cancer Patients Better Survival Estimates
 

A SURVIV analysis of breast cancer isoforms developed at UCLA. Blue lines are associated with longer survival times and magenta lines with shorter survival times.
Image: Courtesy of Dr. Yi Xing

A new method developed by UCLA scientists could lead to a way to produce more reliable projections for survival time and treatment plans for people with cancer. The approach, which uses information about patients’ genetic sequences, is an innovative way of using biomedical big data — which glean patterns and trends from massive amounts of patient information — to achieve precision medicine, giving doctors the ability to better tailor their care for each patient.

The method is likely to enable doctors to give more accurate predictions for people with many types of cancers. In this research, the UCLA scientists studied cancers of the breast, brain (glioblastoma multiforme, a highly malignant and aggressive form, and lower-grade glioma, a less-aggressive version), lung, ovary and kidney. In addition, it may allow scientists to analyze people’s genetic sequences and determine which are lethal and which are harmless.

The new approach analyzes various gene isoforms — combinations of genetic sequences that can produce an enormous variety of RNAs and proteins from a single gene — using data from RNA molecules in cancer specimens. That process, called RNA sequencing, or RNA-seq, reveals the presence and quantity of RNA molecules in a biological sample. In the method developed at UCLA, scientists analyzed the ratios of slightly different genetic sequences within the isoforms, enabling them to detect important but subtle differences in the genetic sequences. In contrast, the conventional analysis aggregates all of the isoforms together, meaning that the technique misses important differences within the isoforms.

SURVIV, which stands for “survival analysis of mRNA isoform variation,” is the first statistical method for conducting survival analysis on isoforms using RNA-seq data, says Yi Xing, PhD, associate professor of microbiology, immunology and molecular genetics and a member of the UCLA Institute for Quantitative and Computational Biosciences.

The researchers identified some 200 isoforms that are associated with survival time for people with breast cancer; some predict longer survival times, while others are linked to shorter times. Armed with that knowledge, scientists might eventually be able to target the isoforms associated with shorter survival times in order to suppress them and fight disease, Dr. Xing says.

The researchers evaluated the performance of survival predictors using a metric called C-index and found that across the six different types of cancer they analyzed, their isoform-based predictions performed consistently better than the conventional gene-based predictions. The result was surprising because it suggests, contrary to conventional wisdom, that isoform ratios provide a more robust molecular signature of cancer patients than overall gene abundance, Dr. Xing says.

The researchers studied tissues from 2,684 people with cancer, whose samples were part of the National Institutes of Health’s Cancer Genome Atlas, and they spent more than two years developing the algorithm for SURVIV. Dr. Xing notes that a human gene typically produces seven-to-10 isoforms. “We have just scratched the surface,” he says. “We will apply the method to much larger data sets, and we expect to learn a lot more.”

“SURVIV for Survival Analysis of mRNA Isoform Variation,” Nature Communications, June 9, 2016


Previous
Impaired Decision-making May Contribute to Parkinson’s Motor Symptoms
Next
UCLA Researchers Grow 3D Lung-in-a-dish


YOU ARE VIEWING

Fall 2016

Fall 2016
E-Brochure
Printable PDF
IN THIS ISSUE
  • Brave New World
  • A Humble Leader
  • Impaired Decision-making May Contribute to Parkinson’s Motor Symptoms
  • Biomarkers Could Give Cancer Patients Better Survival Estimates
  • UCLA Researchers Grow 3D Lung-in-a-dish
  • UCLA Scientists Advance Cancer-screening Technology to Personalize Treatment
  • Heart-failure Therapy Could Reduce Deaths
  • Fructose Alters Brain Genes, Can Lead to Disease
  • New Method to Study Mitochondrial DNA Diseases
  • Potential Treatment Breakthrough for Advanced Brain Cancer
  • UCLA, Danish Researchers Explain How Eliminating HIV Is Possible
  • Eye on the Future
  • The Collaborator
  • Lonely Planet
  • Bridging the Cultural Divide
  • Heart to Heart
  • Awards & Honors
  • In Memoriam
  • The Long Road from California to the CDC
  • Like Father, Like Son
  • Generous Philanthropic Gift Will Name the UCLA Division of Digestive Diseases
  • Cancer Moonshot Summit Aspires to Eclipse Cancer
  • Kaleidoscopic Circus Celebration Raises Money for Children’s Research
  • Who Cares About the Next Generation
  • Cancer Crusader Establishes Women’s Cancer-research Fund
  • Longtime UCLA Benefactor Expands Commitment to Alzheimer’s Care
  • Symposium on Teen Self-image
  • Medical School Alumni Reunite and Tour Geffen Hall
  • Heart Talk: Women’s Heart Health Program Reaches Out to the Community
  • UCLA Medical Center Boards Welcome New Leadership
  • Gifts
  • ACT III
Like Us on Facebook Follow Us on Twitter Subscribe to Our Videos on YouTube Follow us on Instagram Connect with Us on LinkedIn Follow us on Pinterest
UCLA Health hospitals ranked best hospitals by U.S. News & World Report
  • UCLA Health
  • Find a Doctor
  • School of Medicine
  • School of Nursing
  • UCLA Campus
  • Directory
  • Newsroom
  • Subscribe
  • Patient Stories
  • Giving
  • Careers
  • Volunteer
  • International Services
  • Privacy Practices
  • Nondiscrimination
  • Billing
  • Health Plans
  • Emergency
  • Report Broken Links
  • Terms of Use
  • 1-310-825-2631
  • Maps & Directions
  • Contact Us
  • Your Feedback
  • Report Misconduct
  • Get Social
  • Sitemap
Like Us on Facebook Follow Us on Twitter Subscribe to Our Videos on YouTube Follow us on Instagram Connect with Us on LinkedIn Follow us on Pinterest

Sign in to myUCLAhealth

Learn more about myUCLAhealth